Instadose Pharma Corp Stock Performance
| INSD Stock | USD 0 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Instadose Pharma are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Instadose Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Instadose Pharma is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
1 | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of RAAS, HOOD and INSD - ACCESS Newswire | 01/29/2025 |
| Begin Period Cash Flow | 65.00 | |
| Free Cash Flow | -65.00 |
Instadose |
Instadose Pharma Relative Risk vs. Return Landscape
If you would invest 0.11 in Instadose Pharma Corp on December 1, 2024 and sell it today you would earn a total of 0.00 from holding Instadose Pharma Corp or generate 0.0% return on investment over 90 days. Instadose Pharma Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Instadose, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Instadose Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Instadose Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Instadose Pharma Corp, and traders can use it to determine the average amount a Instadose Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| INSD |
Based on monthly moving average Instadose Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Instadose Pharma by adding Instadose Pharma to a well-diversified portfolio.
Instadose Pharma Fundamentals Growth
Instadose Stock prices reflect investors' perceptions of the future prospects and financial health of Instadose Pharma, and Instadose Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Instadose Stock performance.
| Return On Asset | -694.06 | ||||
| Current Valuation | 757.11 K | ||||
| Shares Outstanding | 531.93 M | ||||
| Price To Book | 0.02 X | ||||
| EBITDA | (462.02 K) | ||||
| Net Income | 462.02 K | ||||
| Cash And Equivalents | 5.33 K | ||||
| Total Debt | 162.3 K | ||||
| Debt To Equity | 0.01 % | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (65) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 585.13 K | ||||
| Retained Earnings | (568.38 K) | ||||
| Working Capital | (162.3 K) | ||||
About Instadose Pharma Performance
By analyzing Instadose Pharma's fundamental ratios, stakeholders can gain valuable insights into Instadose Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Instadose Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Instadose Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (225.67) | (236.96) | |
| Return On Capital Employed | 2.60 | 2.73 | |
| Return On Assets | (225.67) | (236.96) | |
| Return On Equity | 2.56 | 2.69 |
Things to note about Instadose Pharma Corp performance evaluation
Checking the ongoing alerts about Instadose Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Instadose Pharma Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Instadose Pharma generated a negative expected return over the last 90 days | |
| Instadose Pharma has some characteristics of a very speculative penny stock | |
| Instadose Pharma Corp currently holds about 5.33 K in cash with (65) of positive cash flow from operations. | |
| Instadose Pharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 34.0% of the company shares are held by company insiders |
- Analyzing Instadose Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Instadose Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Instadose Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Instadose Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Instadose Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Instadose Pharma's stock. These opinions can provide insight into Instadose Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Instadose Stock analysis
When running Instadose Pharma's price analysis, check to measure Instadose Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Instadose Pharma is operating at the current time. Most of Instadose Pharma's value examination focuses on studying past and present price action to predict the probability of Instadose Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Instadose Pharma's price. Additionally, you may evaluate how the addition of Instadose Pharma to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |